Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterActive in the last 2 years

Hiroki Sakamoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0414-7064; OpenAlex author ID A5115565861. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Impact of tumor necrosis on comprehensive genomic profiling success in pancreatic cancer: a retrospective study. Co-author DOI 10.1093/jjco/hyaf156↗
  2. Author reply to letter to the editor: Beyond the ruler: Measuring what truly matters in EUS-guided pancreatic cancer genomics. Co-author DOI 10.1055/a-2677-0491↗
  3. Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis. Co-author DOI 10.3390/cancers10020050↗
  4. A Social Program for the Early Detection of Pancreatic Cancer: The Kishiwada Katsuragi Project. Co-author DOI 10.1159/000481239↗
  5. Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer. Co-author DOI 10.1177/1756283x16644248↗
  6. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2014.10.037↗
  7. Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer. First author DOI 10.1186/1476-4598-13-126↗
  8. Endoscopic ultrasound-guided neurolysis in pancreatic cancer. Co-author DOI 10.1159/000323513↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hirotoshi Ishiwatari · 2 shared papers, 2025–2026 · strength 0.46
  2. Takuya Doi · 2 shared papers, 2025–2026 · strength 0.46
  3. Masatoshi Kudo · 6 shared papers, 2011–2018 · strength 0.30
  4. Masayuki Kitano · 6 shared papers, 2011–2018 · strength 0.30
  5. Tomoko Norose · 1 shared paper, 2026 · strength 0.24
  6. Hiroyuki Ono · 1 shared paper, 2026 · strength 0.24
  7. Hiroyuki ONO · 1 shared paper, 2025 · strength 0.22
  8. Junya Sato · 1 shared paper, 2025 · strength 0.22
  9. Ken Kamata · 3 shared papers, 2011–2018 · strength 0.16
  10. Kosuke Minaga · 2 shared papers, 2016–2018 · strength 0.13
  11. Kentaro Yamao · 2 shared papers, 2016–2018 · strength 0.13
  12. Yosuke Togashi · 2 shared papers, 2014–2015 · strength 0.08
  13. Kazuto Nishio · 2 shared papers, 2014–2015 · strength 0.08
  14. Mamoru Takenaka · 1 shared paper, 2018 · strength 0.07
  15. Atsushi Nakai · 1 shared paper, 2018 · strength 0.07
  16. Kazuhide Higuchi · 1 shared paper, 2017 · strength 0.06
  17. Yoshifumi Takeyama · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.